LivaNova Appoints Susan Podlogar as a New Director
LivaNova PLC (Nasdaq: LIVN) has appointed Susan Podlogar to its Board of Directors, effective immediately. Podlogar, who will serve on the Compensation and Human Capital Management Committee, brings 30 years of experience in leading business, talent, and cultural transformations at global companies. Her most recent role was Executive Vice President, Chief Human Resources Officer at MetLife from July 2017 to June 2024. Prior to that, she spent 16 years at Johnson & Johnson in various leadership positions. Podlogar holds an MBA from the University of South Florida and a bachelor's degree from the University of Wisconsin-Parkside.
William Kozy, Chair of the Board, praised Podlogar's visionary leadership and understanding of the global business landscape. With this appointment, the LivaNova Board now consists of 10 Directors.
LivaNova PLC (Nasdaq: LIVN) ha nominato Susan Podlogar nel suo Consiglio di Amministrazione, con effetto immediato. Podlogar, che farà parte del Comitato per i Compensi e la Gestione del Capitale Umano, porta con sé 30 anni di esperienza nella guida di trasformazioni aziendali, di talento e culturali in aziende globali. Il suo ruolo più recente è stato quello di Executive Vice President, Chief Human Resources Officer in MetLife da luglio 2017 a giugno 2024. Prima di ciò, ha trascorso 16 anni in Johnson & Johnson ricoprendo varie posizioni di leadership. Podlogar ha conseguito un MBA presso l'Università della Florida del Sud e una laurea presso l'Università del Wisconsin-Parkside.
William Kozy, Presidente del Consiglio, ha lodato la leadership visionaria di Podlogar e la sua comprensione del panorama aziendale globale. Con questa nomina, il Consiglio di LivaNova ora è composto da 10 Direttori.
LivaNova PLC (Nasdaq: LIVN) ha nombrado a Susan Podlogar en su Junta Directiva, con efecto inmediato. Podlogar, quien formará parte del Comité de Compensación y Gestión de Capital Humano, aporta 30 años de experiencia en liderar transformaciones empresariales, de talento y culturales en empresas globales. Su último cargo fue Vicepresidenta Ejecutiva, Directora de Recursos Humanos en MetLife desde julio de 2017 hasta junio de 2024. Antes de eso, pasó 16 años en Johnson & Johnson ocupando diversas posiciones de liderazgo. Podlogar tiene un MBA de la Universidad del Sur de Florida y una licenciatura de la Universidad de Wisconsin-Parkside.
William Kozy, Presidente de la Junta, elogió el liderazgo visionario de Podlogar y su comprensión del panorama empresarial global. Con este nombramiento, la Junta de LivaNova ahora consta de 10 Directores.
LivaNova PLC (Nasdaq: LIVN)가 Susan Podlogar를 이사회에 즉시 임명했습니다. Podlogar는 보상 및 인적 자원 관리 위원회에서 활동하며, 30년의 경험을 바탕으로 글로벌 기업에서 비즈니스, 인재 및 문화 변화를 이끌어왔습니다. 그녀의 최근 역할은 2017년 7월부터 2024년 6월까지 MetLife의 Executive Vice President, Chief Human Resources Officer였습니다. 그 이전에는 Johnson & Johnson에서 16년 동안 다양한 리더십 직책을 맡았습니다. Podlogar는 플로리다 남부대학교에서 MBA를, 위스콘신-파크사이드대학교에서 학사 학위를 취득했습니다.
이사회 의장인 William Kozy는 Podlogar의 비전 있는 리더십과 글로벌 비즈니스 환경에 대한 이해를 높이 평가했습니다. 이번 임명으로 LivaNova 이사회는 이제 10명의 이사로 구성되어 있습니다.
LivaNova PLC (Nasdaq: LIVN) a nommé Susan Podlogar à son Conseil d'Administration, avec effet immédiat. Podlogar, qui siégera au Comité des Rémunérations et de Gestion des Ressources Humaines, apporte 30 ans d'expérience dans la conduite de transformations organisationnelles, de talents et culturelles au sein d'entreprises mondiales. Son dernier poste était Vice-Présidente Exécutive, Directrice des Ressources Humaines chez MetLife de juillet 2017 à juin 2024. Avant cela, elle a passé 16 ans chez Johnson & Johnson à divers postes de direction. Podlogar est titulaire d'un MBA de l'Université du Sud de la Floride et d'une licence de l'Université du Wisconsin-Parkside.
William Kozy, Président du Conseil, a salué le leadership visionnaire de Podlogar et sa compréhension du paysage commercial mondial. Avec cette nomination, le Conseil de LivaNova compte désormais 10 Directeurs.
LivaNova PLC (Nasdaq: LIVN) hat Susan Podlogar mit sofortiger Wirkung in seinen Vorstand berufen. Podlogar wird im Ausschuss für Vergütung und Human Capital Management tätig sein und bringt 30 Jahre Erfahrung in der Leitung von geschäftlichen, talentbezogenen und kulturellen Transformationen bei globalen Unternehmen mit. Ihre letzte Position war als Executive Vice President, Chief Human Resources Officer bei MetLife von Juli 2017 bis Juni 2024. Davor war sie 16 Jahre bei Johnson & Johnson in verschiedenen Führungspositionen tätig. Podlogar hat einen MBA von der University of South Florida und einen Bachelor-Abschluss von der University of Wisconsin-Parkside.
William Kozy, Vorsitzender des Vorstands, lobte Podlogars visionäre Führung und ihr Verständnis für die globale Geschäftswelt. Mit dieser Ernennung besteht der LivaNova-Vorstand jetzt aus 10 Direktoren.
- Appointment of Susan Podlogar brings 30 years of global leadership experience to the Board
- Podlogar's expertise in business, talent, and cultural transformations could benefit LivaNova's strategic direction
- The new director's experience with prominent companies like MetLife and Johnson & Johnson may provide valuable insights
- None.
“LivaNova’s Board of Directors is pleased to welcome Susan Podlogar,” said William Kozy, Chair of the Board. “Susan is a visionary leader with three decades of experience in leading business, talent, and cultural transformations at recognized global companies. She possesses a sharp understanding of the ever-changing global business landscape and will be a tremendous asset to the Board.”
Podlogar’s career spans 30 years, holding key global leadership positions at prominent institutions in the consulting, scientific, and financial sectors. Most recently, she served as the Executive Vice President, Chief Human Resources Officer at MetLife from July 2017 until her retirement in June 2024. Prior to MetLife, Podlogar spent 16 years at Johnson & Johnson in various leadership roles, including: Global Head, Human Resources Medical Devices; Global Head of Total Rewards and Head Human Resources for
“What an honor to join the Board for LivaNova, knowing that the Company’s life-changing medical technologies advance the quality of life for patients around the world,” said Podlogar. “I look forward to using my experiences to help LivaNova deepen the commitment to patients and customers, while driving value for the shareholders.”
With this appointment, the LivaNova Board is now comprised of 10 Directors.
About LivaNova
LivaNova PLC is a global medical technology company built on nearly five decades of experience and a relentless commitment to provide hope for patients and their families through medical technologies, delivering life-changing solutions in select neurological and cardiac conditions. Headquartered in
Safe Harbor Statement
This news release contains “forward-looking statements” concerning the Company’s goals, beliefs, expectations, strategies, objectives, plans, underlying assumptions, and other statements that are not necessarily based on historical facts. These statements include, but are not limited to, statements regarding the Board of Directors. Actual events may differ materially from those indicated in our forward-looking statements as a result of various factors, including those factors set forth in Item 1A of the Company’s most recent Annual Report on Form 10-K, as supplemented by any risk factors contained in Quarterly Reports on Form 10-Q and Current Reports on Form 8-K. LivaNova undertakes no obligation to update the information contained in this press release to reflect subsequently occurring events or circumstances.
View source version on businesswire.com: https://www.businesswire.com/news/home/20241008398648/en/
LivaNova Investor Relations and Media Contacts
+1 281-895-2382
Briana Gotlin
Director, Investor Relations
InvestorRelations@livanova.com
Deanna Wilke
VP, Corporate Communications
Corporate.Communications@livanova.com
Source: LivaNova PLC
FAQ
Who is the new director appointed to LivaNova's (LIVN) Board?
What committee will Susan Podlogar serve on for LivaNova (LIVN)?
What was Susan Podlogar's most recent position before joining LivaNova's (LIVN) Board?
How many directors are now on LivaNova's (LIVN) Board after this appointment?
